In addition, CXCR2-expressing CAR-T cells were more sensitive to the IL-8-rich microenvironment in pancreatic cancer and had stronger anti-tumor activity against αvβ6-expressing pancreatic tumor xenografts [58]. This evidence concerns the gene CXCL8 and pancreatic neoplasm.